Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation in First Line High Risk Multiple Myeloma Patients: Evolving Strategies with the Immunomodulating Drugs.

Mauricette Michallet, MD, PhD, Mohamad Sobh, Pharm.M., Jean El-Cheikh, MD PhD, Stéphane Morisset, Stat., Anne Sirvent, MD, Oumedaly Reman, MD, Jérôme Cornillon, MD, Reza Tabrizi, MD, Noel Milpied, MD, Jean-Luc Harousseau, MD, Hélène Labussière-Wallet, MD, Franck E. Nicolini, MD, PhD, Charles Dumontet, M. D., Ph.D., Mohamad Mohty, Michel Attal, MD, Didier Blaise, MD, Philippe Moreau, MD, Hervé Avet-Loiseau, MD, PhD

Blood (2012) 120 (21): 3116.

https://doi.org/10.1182/blood.V120.21.3116.3116

Published: 2012

Journal Articles

HLA-DRB4 Mismatch Is Associated with Worse Outcomes in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies

Marie Y. Detrait, MD, Ibrahim Yakoub-Agha, MD, PhD, Valerie Dubois, MD, Françoise Dufossé, Myriam Labalette, Mohamad Sobh, Pharm.M., Stéphane Morisset, Stat., Nathalie Tedone, CRA, Sylvie Rey, Elodie Morais, Mauricette Michallet, MD, PhD

Blood (2012) 120 (21): 4540.

https://doi.org/10.1182/blood.V120.21.4540.4540

Published: 2012

Journal Articles

Flamsa-RIC Sequential Regimen in High Risk CR1 AML Patients: Preliminary Results From a Pilot Study

Blood (2012) 120 (21): 4549.

https://doi.org/10.1182/blood.V120.21.4549.4549

Published: 2012

Journal Articles

Iron Overload in Patients with Hematological Disorders Undergoing Allogeneic HSCT: Unrevealed Implication in Different Outcomes

Mauricette Michallet, MD, PhD, Mohamad Sobh, Pharm.M., Stéphane Morisset, Stat., Hélène Labussière-Wallet, MD, Marie Y. Detrait, MD, Sophie Ducastelle, MD, Fiorenza Barraco, MD, Youcef Chelghoum, MD, Anne Cordonnier, Richard Cohen, Xavier Thomas, MD, Franck E. Nicolini, MD, PhD, Colette Chapuis-Cellier, MD

Blood (2012) 120 (21): 4527.

https://doi.org/10.1182/blood.V120.21.4527.4527

Published: 2012

Journal Articles

Risk Factors to Develop Sclerotic Chronic GvHD After Allogeneic HSCT: Preliminary Results of a Multicentre Retrospective study From the Société Française De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)

Marie Y. Detrait, MD, Roberto Crocchiolo, MD PhD, Stephane Vigouroux, MD, Jacques-Olivier Bay, MD, PhD, Mohamad Sobh, Pharm.M., Fiorenza Barraco, MD, Stéphane Morisset, Stat., Reza Tabrizi, MD, Nicole Raus, Regis Peffault de la Tour, Gérard Socié, MD PhD, Ibrahim Yakoub-Agha, MD, PhD, Mohamad Mohty, MD PhD, Noel Milpied, MD, Didier Blaise, MD, Mauricette Michallet, MD, PhD

Blood (2012) 120 (21): 1947.

https://doi.org/10.1182/blood.V120.21.1947.1947

Published: 2012

Journal Articles

MMR and CMR in Chronic Phase Chronic Myeloid Leukemia Patients: Role of Sokal Score and Different Tyrosine Kinase Inhibitors On Time of Their Obtention, Maintenance and Failure-Free Survival

Mauricette Michallet, MD, PhD, Hélène Labussière-Wallet, MD, Mohamad Sobh, Pharm.M., Stéphane Morisset, Stat., Madeleine Etienne, CRA, Marie Y. Detrait, MD, Sophie Ducastelle, MD, Fiorenza Barraco, MD, Xavier Thomas, MD, Oriane Le Borgne, CRA, Isabelle Tigaud, MD, Sandrine Hayette, Franck E. Nicolini, MD, PhD

Blood (2012) 120 (21): 4437.

https://doi.org/10.1182/blood.V120.21.4437.4437

Published: 2012

Journal Articles

A New Score to Determine the Probability of Finding an HLA Identical Unrelated Donor: A Validated Efficient Time and Cost Saving Method

Valéerie Dubois, MD, Mohamad Sobh, Pharm.M., Stéphane Morisset, Stat., Hélène Labussière-Wallet, MD, Marie Y. Detrait, MD, Sylvie Rey, Isabelle Mollet, Sophie Ducastelle, MD, Fiorenza Barraco, MD, Youcef Chelghoum, MD, Xavier Thomas, MD, Franck E. Nicolini, MD, PhD, Mauricette Michallet, MD, PhD

Blood (2012) 120 (21): 604.

https://doi.org/10.1182/blood.V120.21.604.604

Published: 2012

Journal Articles

Azacitidine Use in MDS and AML Patients: Best Selection for Better Results

Mauricette Michallet, MD, PhD, Mohamad Sobh, Pharm. M., Stéphane Morisset, Stat., Carine Champigneulle, CRA, Florence Ranchon, Marie Y. Detrait, MD, Hélène Labussière-Wallet, MD, Sophie Ducastelle, MD, Franck E. Nicolini, MD, PhD, Youcef Chelghoum, MD, Xavier Thomas, MD, Caroline Le jeune, MD, Eric Wattel, MD, PhD, Catherine Rioufol, PharmD, Fiorenza Barraco, MD

Blood (2012) 120 (21): 5070.

https://doi.org/10.1182/blood.V120.21.5070.5070

Published: 2012

Journal Articles

Cytokine Gene Polymorphisms and Severe Acute Graft-Versus-Host Disease (grade ≥II) After Allogeneic Hematopoietic Stem Cell Transplantation From HLA Identical Siblings

Valérie Dubois, MD, Mohamad Sobh, Pharm.M., Stéphane Morisset, Stat., Hélène Labussière-Wallet, MD, Marie Y. Detrait, MD, Sylvie Rey, Isabelle Mollet, Sophie Ducastelle, MD, Fiorenza Barraco, MD, Youcef Chelghoum, MD, Xavier Thomas, MD, Franck E. Nicolini, MD, PhD, Mauricette Michallet, MD, PhD

Blood (2012) 120 (21): 4180.

https://doi.org/10.1182/blood.V120.21.4180.4180

Published: 2012

NARROW

Allogeneic Hematopoietic Stem Cell Transplantation in First Line High Risk Multiple Myeloma Patients: Evolving Strategies with the Immunomodulating Drugs.

HLA-DRB4 Mismatch Is Associated with Worse Outcomes in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies

Flamsa-RIC Sequential Regimen in High Risk CR1 AML Patients: Preliminary Results From a Pilot Study

Iron Overload in Patients with Hematological Disorders Undergoing Allogeneic HSCT: Unrevealed Implication in Different Outcomes

Risk Factors to Develop Sclerotic Chronic GvHD After Allogeneic HSCT: Preliminary Results of a Multicentre Retrospective study From the Société Française De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)

MMR and CMR in Chronic Phase Chronic Myeloid Leukemia Patients: Role of Sokal Score and Different Tyrosine Kinase Inhibitors On Time of Their Obtention, Maintenance and Failure-Free Survival

A New Score to Determine the Probability of Finding an HLA Identical Unrelated Donor: A Validated Efficient Time and Cost Saving Method

Azacitidine Use in MDS and AML Patients: Best Selection for Better Results

Cytokine Gene Polymorphisms and Severe Acute Graft-Versus-Host Disease (grade ≥II) After Allogeneic Hematopoietic Stem Cell Transplantation From HLA Identical Siblings

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only